Université Henri Poincaré, Nancy Université, Nancy, France.
Physiol Behav. 2010 Apr 26;100(1):15-21. doi: 10.1016/j.physbeh.2010.02.026. Epub 2010 Mar 6.
The constant supply of oxygen and nutriments to cells (especially neurons) is the role of the cardiovascular system. The constant supply of water (and sodium) for cardiovascular function is the role of thirst and sodium appetite and kidney function. This physiological regulation ensures that plasma volume and osmolality are maintained within set limits by initiating behaviour and release of hormones necessary to ingest and conserve water and sodium within the body. This regulation is separated into 2 parts; intracellular and extracellular (blood). An increased osmolality draws water from cells into the blood thus dehydrating specific brain osmoreceptors that stimulate drinking and release of anti diuretic hormone (ADH or vasopressin). ADH reduces water loss via lowered urine volume. Extracellular dehydration (hypovolaemia) stimulates specific vascular receptors that signal brain centres to initiate drinking and ADH release. Baro/volume receptors in the kidney participate in stimulating the release of the enzyme renin that starts a cascade of events to produce angiotensin II (AngII), which initiates also drinking and ADH release. This stimulates also aldosterone release which reduces kidney loss of urine sodium. Both AngII and ADH are vasoactive hormones that could work to reduce blood vessel diameter around the remaining blood. All these events work in concert so that the cardiovascular system can maintain a constant perfusion pressure, especially to the brain. Even if drinking does not take place ADH, AngII and aldosterone are still released. Furthermore, it has been observed that treatment of hypertension, obesity, diabetes and cancer can involve renin-AngII antagonists which could suggest that, in humans at least, there may be dysfunction of the thirst regulatory mechanism.
细胞(尤其是神经元)的氧气和营养物质的持续供应是心血管系统的作用。水(和钠)的持续供应以维持心血管功能是口渴、钠欲和肾功能的作用。这种生理调节确保通过启动行为和释放摄入和保留体内水和钠所必需的激素,将血浆容量和渗透压维持在设定的范围内。这种调节分为细胞内和细胞外(血液)两部分。渗透压升高会将水从细胞中吸入血液,从而使特定的脑渗透压感受器脱水,刺激饮水和抗利尿激素(ADH 或加压素)的释放。ADH 通过降低尿量减少水的流失。细胞外脱水(低血容量)会刺激特定的血管受体,向大脑中枢发出信号,启动饮水和 ADH 释放。肾脏中的压力/容量受体参与刺激释放酶肾素,该酶启动一系列事件产生血管紧张素 II(AngII),这也会引发饮水和 ADH 释放。这也会刺激醛固酮的释放,减少肾脏尿液中钠的流失。AngII 和 ADH 都是血管活性激素,可作用于减少血管周围剩余血液的血管直径。所有这些事件协同作用,使心血管系统能够维持恒定的灌注压力,特别是对大脑。即使不饮水,ADH、AngII 和醛固酮仍会被释放。此外,已经观察到高血压、肥胖、糖尿病和癌症的治疗可能涉及肾素-血管紧张素拮抗剂,这表明至少在人类中,口渴调节机制可能存在功能障碍。